LifeStance Health
LFST

LifeStance Health (LFST) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BTIGMaintainedBuy$18.00 from $16.00Aug 19, 2026
JP MorganMaintainedNeutral$13.00 from $9.00Aug 14, 2026
BTIGMaintainedBuy$16.00 from $15.00Aug 7, 2026
BTIGMaintainedBuy$15.00 from $12.00Jul 24, 2026
Canaccord GenuityMaintainedBuy$13.00 from $11.00Jul 21, 2026
BarclaysMaintainedOverweight$13.00 from $9.00Jul 14, 2026
KeybancMaintainedOverweight$13.00 from $11.00Jul 13, 2026
Goldman SachsInitiated CoverageBuy → Neutral$9.00Jun 5, 2026
JP MorganMaintainedNeutral$9.00 from $8.00May 14, 2026
BTIGMaintainedBuy$12.00 from $11.00May 8, 2026
BarclaysMaintainedOverweight$9.00 from $8.00Mar 6, 2026
KeybancMaintainedOverweight$9.00 from $8.00Feb 26, 2026
UBSMaintainedBuy$12.00 from $10.00Feb 26, 2026
Canaccord GenuityMaintainedBuy$10.00 from $9.00Feb 26, 2026
BTIGMaintainedBuy$11.00 from $10.00Feb 2, 2026
BTIGMaintainedBuy$10.00 from $9.00Dec 12, 2025
BarclaysInitiated CoverageOverweight$8.00Dec 9, 2025
BMO CapitalInitiated CoverageOutperform$8.00Nov 13, 2025
UBSMaintainedBuy$10.00 from $9.00Nov 7, 2025
BTIGMaintainedBuy$9.00 from $8.00Nov 6, 2025

Frequently asked questions

  • What is the latest analyst rating on LFST?

    On Aug 19, 2026, BTIG maintained LifeStance Health at Buy with a price target of $18.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.